AR067471A1 - Un componente de vacuna anti- pertussis y procedimiento simplificado para obtener pertactina ( prn ) de bordetella pertussis - Google Patents

Un componente de vacuna anti- pertussis y procedimiento simplificado para obtener pertactina ( prn ) de bordetella pertussis

Info

Publication number
AR067471A1
AR067471A1 ARP080102932A ARP080102932A AR067471A1 AR 067471 A1 AR067471 A1 AR 067471A1 AR P080102932 A ARP080102932 A AR P080102932A AR P080102932 A ARP080102932 A AR P080102932A AR 067471 A1 AR067471 A1 AR 067471A1
Authority
AR
Argentina
Prior art keywords
pertussis
prn
pertactin
vaccine
component
Prior art date
Application number
ARP080102932A
Other languages
English (en)
Inventor
M L Mago
Rajesh Jain
Original Assignee
Panacea Biotec Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Panacea Biotec Ltd filed Critical Panacea Biotec Ltd
Publication of AR067471A1 publication Critical patent/AR067471A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A61K39/39533—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals
    • A61K39/39558—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals against tumor tissues, cells, antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Oncology (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Communicable Diseases (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)

Abstract

Un componente de vacuna anti-pertusis obteniendo antígeno Pertactina (PRN) desde Bordetella pertussis. Un proceso simplificado para la extraccion y purificacion de Pertactina (PRN). La Pertactina obtenida por este procedimiento tiene un nivel de pureza mayor de 90% y el procedimiento usado en la presente previene la pérdida de PRN al evitar pasos complejos de procesamiento. La proteína de membrana externa (OMP) purificada por el procedimiento de la presente utiliza un proceso simplificado y es util en la preparacion de Vacunas Acelulares Anti-Pertussis, tanto sola como parte de combinaciones de vacunas. Reivindicacion 15: Un procedimiento para usar el componente de vacuna segun la reivindicacion 1, caracterizado porque comprende administrar a un sujeto necesitado de ello una cantidad del componente de vacuna.
ARP080102932A 2007-07-31 2008-07-07 Un componente de vacuna anti- pertussis y procedimiento simplificado para obtener pertactina ( prn ) de bordetella pertussis AR067471A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IN1618DE2007 2007-07-31

Publications (1)

Publication Number Publication Date
AR067471A1 true AR067471A1 (es) 2009-10-14

Family

ID=40303927

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP080102932A AR067471A1 (es) 2007-07-31 2008-07-07 Un componente de vacuna anti- pertussis y procedimiento simplificado para obtener pertactina ( prn ) de bordetella pertussis

Country Status (3)

Country Link
AR (1) AR067471A1 (es)
CL (1) CL2008002003A1 (es)
WO (1) WO2009016651A1 (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8574589B2 (en) * 2009-05-11 2013-11-05 Novartis Ag Antigen purification process for pertactin antigen
US10329323B2 (en) 2014-07-25 2019-06-25 The United States Of America, As Represented By The Secretary, Department Of Health & Human Services Method for purifying antibodies using PBS
KR102426041B1 (ko) * 2017-08-01 2022-07-29 주식회사 녹십자 냉동 및 해동 과정을 포함하는 백일해균 유래 단백질 수득 방법

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9007657D0 (en) * 1990-04-04 1990-05-30 Connaught Lab Purification of a pertussis outer membrane protein(omp69)
BR9710460A (pt) * 1996-07-02 1999-08-17 Connaught Lab Composi-Æo imunolÄgica multi-valente e seu uso em vacinas

Also Published As

Publication number Publication date
CL2008002003A1 (es) 2008-11-03
WO2009016651A1 (en) 2009-02-05

Similar Documents

Publication Publication Date Title
AR107020A2 (es) Vacuna de pcsk9 (proteína convertasa subtilisina-kexina tipo 9)
PE20100366A1 (es) Novedosas composiciones de vacuna con tos ferina acelular asi como el metodo para su elaboracion
EA200801221A1 (ru) Вирусные вакцины, полученные из клеток, с низкими уровнями остаточной клеточной днк
AR061152A1 (es) Vacuna recombinante contra virus de la lengua azul
MX2019005137A (es) Vacuna contra parvovirus porcino.
WO2022043551A3 (en) Multivalent nucleic acid based coronavirus vaccines
PE20080748A1 (es) Vacuna a base de los de cepas de neisseria
EA200900289A1 (ru) Вакцина
EA201170493A1 (ru) Микроорганизмы и вакцины, зависимые от репликации неприродных аминокислот
MX363409B (es) Antigenos y vacunas dirigidos contra enterovirus hunanos.
BR112013011194A2 (pt) partículas de glicoproteína semelhantes a vírus (vlps) da raiva.
PE20190458A1 (es) Composiciones de neisseria meningitidis y metodos de las mismas
JP2009514840A5 (es)
WO2009152147A3 (en) Compositions and methods for dengue virus (dv) treatment and vaccination
BE1022008B1 (fr) Compositions immunogenes combinees
PE20100365A1 (es) Novedosas vacunas de combinacion con tos ferina de celulas enteras y metodo para su elaboracion
RU2014127714A (ru) ВАКЦИНА НА ОСНОВЕ ТОКСИНОВ Clostridium difficile
PH12015501875A1 (en) Acellular pertussis vaccine
UA114286C2 (uk) Спосіб лікування staphylococcus aureus
AR067471A1 (es) Un componente de vacuna anti- pertussis y procedimiento simplificado para obtener pertactina ( prn ) de bordetella pertussis
PH12019500404A1 (en) Multivalent vaccine composition
NZ738909A (en) Protease-resistant lipidated glp-1 analogs
CL2013002631A1 (es) Virus de la necrosis pancreatica infecciosa (ipnv) avirulento porque comprende proteina vp2 madura.
DE60336588D1 (de) Verbesserte anthraximpfstoffe und abgabeverfahren
MX2010003220A (es) Proteinas inmunogenicas de membrana exterior derivada de genoma de leptospira y composiciones y metodos basados en las mismas.

Legal Events

Date Code Title Description
FB Suspension of granting procedure